Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Levine

Showing results (661-670 of 680) with videos related to

Pageof 68
Sort By:
Journal of the American College of Cardiology|May 14, 2021
Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart DiseaseMeena Nathan, Jami C Levine, Maria I Van Rompay, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Lancet (London, England)|October 22, 2017
Evidence-based guidelines for supportive care of patients with Ebola virus diseaseFrançois Lamontagne, Robert A Fowler, Neill K Adhikari, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
JAMA|May 26, 2018
Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income CountriesKristina E Rudd, Christopher W Seymour, Adam R Aluisio, et al.
The New England Journal of Medicine|November 19, 2014
Atenolol versus losartan in children and young adults with Marfan's syndromeRonald V Lacro, Harry C Dietz, Lynn A Sleeper, et al.
The Journal of Clinical Investigation|May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growthJaya Sangodkar, Abbey Perl, Rita Tohme, et al.
The New England Journal of Medicine|November 28, 2019
A Randomized, Controlled Trial of Ebola Virus Disease TherapeuticsSabue Mulangu, Lori E Dodd, Richard T Davey, et al.
The Lancet. Microbe|September 2, 2023
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort studyXianming Zhu, Kelly A Gebo, Alison G Abraham, et al.
Microbiology Spectrum|November 27, 2023
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trialFeben Habtehyimer, Xianming Zhu, Andrew D Redd, et al.
Pageof 68

Showing results (661-670 of 680) with videos related to

Sort By:
Pageof 68
Journal of the American College of Cardiology|May 14, 2021
Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart DiseaseMeena Nathan, Jami C Levine, Maria I Van Rompay, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Lancet (London, England)|October 22, 2017
Evidence-based guidelines for supportive care of patients with Ebola virus diseaseFrançois Lamontagne, Robert A Fowler, Neill K Adhikari, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
JAMA|May 26, 2018
Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income CountriesKristina E Rudd, Christopher W Seymour, Adam R Aluisio, et al.
The New England Journal of Medicine|November 19, 2014
Atenolol versus losartan in children and young adults with Marfan's syndromeRonald V Lacro, Harry C Dietz, Lynn A Sleeper, et al.
The Journal of Clinical Investigation|May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growthJaya Sangodkar, Abbey Perl, Rita Tohme, et al.
The New England Journal of Medicine|November 28, 2019
A Randomized, Controlled Trial of Ebola Virus Disease TherapeuticsSabue Mulangu, Lori E Dodd, Richard T Davey, et al.
The Lancet. Microbe|September 2, 2023
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort studyXianming Zhu, Kelly A Gebo, Alison G Abraham, et al.
Microbiology Spectrum|November 27, 2023
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trialFeben Habtehyimer, Xianming Zhu, Andrew D Redd, et al.
Pageof 68